137 related articles for article (PubMed ID: 9890338)
1. Thrombin-antithrombin III and D-dimer plasma levels in patients with benign or malignant ovarian tumours.
den Ouden M; Ubachs JM; Stoot JE; van Wersch JW
Scand J Clin Lab Invest; 1998 Nov; 58(7):555-9. PubMed ID: 9890338
[TBL] [Abstract][Full Text] [Related]
2. Coagulation and fibrinolysis activation markers in prostatic carcinoma patients.
Geenen RW; Delaere KP; van Wersch JW
Eur J Clin Chem Clin Biochem; 1997 Feb; 35(2):69-72. PubMed ID: 9056745
[TBL] [Abstract][Full Text] [Related]
3. Hemostatic and fibrinolytic status in patients with ovarian cancer and benign ovarian cysts: could D-dimer and antithrombin III levels be included as prognostic markers for survival outcome?
Koh SC; Tham KF; Razvi K; Oei PL; Lim FK; Roy AC; Prasad RN
Clin Appl Thromb Hemost; 2001 Apr; 7(2):141-8. PubMed ID: 11292192
[TBL] [Abstract][Full Text] [Related]
4. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
[TBL] [Abstract][Full Text] [Related]
5. A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen.
Boisclair MD; Lane DA; Wilde JT; Ireland H; Preston FE; Ofosu FA
Br J Haematol; 1990 Apr; 74(4):471-9. PubMed ID: 2189490
[TBL] [Abstract][Full Text] [Related]
6. Coagulation and fibrinolysis markers in seminal plasma of patients under evaluation for involuntary childlessness.
van Wersch JW; De Vries-Hanje JC; Ubachs JM
Eur J Clin Chem Clin Biochem; 1992 Aug; 30(8):467-71. PubMed ID: 1445960
[TBL] [Abstract][Full Text] [Related]
7. Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock.
Gando S; Nanzaki S; Sasaki S; Aoi K; Kemmotsu O
Crit Care Med; 1998 Dec; 26(12):2005-9. PubMed ID: 9875912
[TBL] [Abstract][Full Text] [Related]
8. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
[TBL] [Abstract][Full Text] [Related]
9. Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women.
Bombeli T; Raddatz-Mueller P; Fehr J
Am J Obstet Gynecol; 2001 Feb; 184(3):382-9. PubMed ID: 11228491
[TBL] [Abstract][Full Text] [Related]
10. Severity of peripheral atherosclerosis is associated with fibrinogen and degradation of cross-linked fibrin.
Lassila R; Peltonen S; Lepäntalo M; Saarinen O; Kauhanen P; Manninen V
Arterioscler Thromb; 1993 Dec; 13(12):1738-42. PubMed ID: 8241093
[TBL] [Abstract][Full Text] [Related]
11. Determination of markers of coagulation activation and reactive fibrinolysis in patients with mechanical heart valve prosthesis at different intensities of oral anticoagulation.
van Wersch JW; van Mourik-Alderliesten CH; Coremans A
Blood Coagul Fibrinolysis; 1992 Apr; 3(2):183-6. PubMed ID: 1606289
[TBL] [Abstract][Full Text] [Related]
12. Relationship between changes in F1+2 and TAT levels and blood coagulation early after prosthetic valve replacement.
Nakamura K; Toyohira H; Kariyazono H; Yamada K; Moriyama Y; Taira A
Thromb Res; 1997 Apr; 86(2):161-71. PubMed ID: 9175237
[TBL] [Abstract][Full Text] [Related]
13. D-dimer, Fibrinogen and Tumor Marker Levels in Patients with benign and Malignant Ovarian Tumors.
Farzaneh F; Salimnezhad M; Hosseini MS; Ashraf Ganjouee T; Arab M; Talayeh M
Asian Pac J Cancer Prev; 2023 Dec; 24(12):4263-4268. PubMed ID: 38156862
[TBL] [Abstract][Full Text] [Related]
14. Increased heparin-releasable platelet factor 4 and D dimer in patients one month after the onset of acute myocardial infarction: persistent activation of platelets and the coagulation/fibrinolytic system.
Abe S; Maruyama I; Arima S; Yamaguchi H; Okino H; Hamasaki S; Yamashita T; Nomoto K; Tahara M; Atsuchi Y
Int J Cardiol; 1994 Dec; 47(1 Suppl):S7-12. PubMed ID: 7737755
[TBL] [Abstract][Full Text] [Related]
15. Fibrinogen, D-dimer and thrombin-antithrombin complexes in a random population sample: relationships with other cardiovascular risk factors.
Giansante C; Fiotti N; Cattin L; Da Col PG; Calabrese S
Thromb Haemost; 1994 May; 71(5):581-6. PubMed ID: 8091384
[TBL] [Abstract][Full Text] [Related]
16. Blood clotting activation analysis for preoperative differentiation of benign versus malignant ovarian masses.
Amirkhosravi A; Bigsby G; Desai H; Rivera-Amaya M; Coll E; Robles-Carrillo L; Faust P; Waters A; Meyer T; Reyes E; Langer F; Francis JL
Blood Coagul Fibrinolysis; 2013 Jul; 24(5):510-7. PubMed ID: 23406663
[TBL] [Abstract][Full Text] [Related]
17. Activation of coagulation and fibrinolytic systems in patients with CLI is not normalized after surgical revascularisation.
Pärsson H; Holmberg A; Siegbahn A; Bergqvist D
Eur J Vasc Endovasc Surg; 2004 Feb; 27(2):186-92. PubMed ID: 14718902
[TBL] [Abstract][Full Text] [Related]
18. Endothelial cell markers and fibrinopeptide A to D-dimer ratio as a measure of coagulation and fibrinolysis balance in normal pregnancy.
Bellart J; Gilabert R; Miralles RM; Monasterio J; Cabero L
Gynecol Obstet Invest; 1998; 46(1):17-21. PubMed ID: 9692335
[TBL] [Abstract][Full Text] [Related]
19. [Role and clinical significance of coagulation and inflammatory factors in moderate and severe ovarian endometriosis].
Lin Q; Ding SJ; Zhu TH; Li TT; Huang XF; Zhang XM
Zhonghua Fu Chan Ke Za Zhi; 2018 Mar; 53(3):167-171. PubMed ID: 29609230
[No Abstract] [Full Text] [Related]
20. Thrombin-antithrombin III-complex & fibrin degradation products in plasma: surgery and postoperative deep venous thrombosis.
Jørgensen LN; Lind B; Hauch O; Leffers A; Albrecht-Beste E; Konradsen LA
Thromb Res; 1990 Jul; 59(1):69-76. PubMed ID: 2205019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
